Symbol="IMVT"
AssetType="Common Stock"
Name="ImmunovantÂ Inc"
Description="Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. The company is headquartered in New York, New York."
CIK="1764013"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="320 WEST 37TH STREET, NEW YORK, NY, US"
FiscalYearEnd="March"
LatestQuarter="2023-06-30"
MarketCapitalization="2643462000"
EBITDA="-233676000"
PERatio="None"
PEGRatio="None"
BookValue="2.297"
DividendPerShare="0"
DividendYield="0"
EPS="-1.94"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.361"
ReturnOnEquityTTM="-0.664"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.94"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="29.92"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.727"
EVToRevenue="-"
EVToEBITDA="-8.22"
Beta="0.952"
num_52WeekHigh="25.13"
num_52WeekLow="4.26"
num_50DayMovingAverage="20.92"
num_200DayMovingAverage="17.88"
SharesOutstanding="130672000"
DividendDate="None"
ExDividendDate="None"
symbol="IMVT"
open="20.50"
high="20.88"
low="20.20"
price="20.22"
volume="1103343.00"
latest_trading_day="2023-08-23"
previous_close="20.57"
change="-0.35"
change_percent="-1.7015%"
aroon_positive_momentum_days="78"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="78"
Volume_recent_avg="1064119"
Change_recent_avg="0.03"
Delta_recent_avg="0.93"
Variance_recent_avg="0.46"
Change_ratio_recent_avg="0.11"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="78"
Aroon_momentum_negative="22"
image_negative_thumbnail_id_1="1099"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0132.jpeg"
image_negative_thumbnail_id_2="495"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0110.jpeg"
image_neutral_thumbnail_id_1="529"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_neutral_thumbnail_id_2="544"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_positive_thumbnail_id_1="984"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0146.jpeg"
image_positive_thumbnail_id_2="668"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0040.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
